Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan 27;12(1):17.
doi: 10.1038/s41408-021-00602-4.

Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study

Hira Mian  1 , Rinku Sutradhar  2   3 , Gregory R Pond  4 , Branavan Sivapathasundaram  4 , Jonathan Sussman  4 , Amaris Balitsky  4 , Anita D'Souza  5 , Tanya M Wildes  6 , Hsien Seow  4
Affiliations
Editorial

Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study

Hira Mian et al. Blood Cancer J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

HM: Consultancy/Honoraria fees from Celgene, Takeda, Janssen, Amgen, Sanofi, Research funding Janssen. RS: None. GP: Current hold of individual stocks of Roche Canada. Consultancy fees from Astra-Zeneca, Merck and Profound Medical. Membership on Advisory committee for Takeda. TW: Consultancy fees from Janssen, Carevive, Seattle Genetics, Sanofi. AD: Institutional Research Funding from Sanofi, Takeda, TeneoBio, Caelum, Prothena, Consultancy/Advisory Board fees- Janssen, Prothena, Imbrium, Pfizer, BMS. AB: None. BS: None. JS: None. HS: None.

Figures

Fig. 1
Fig. 1
Proportion of patients in the cohort who presented to the emergency department/hospitalization within 14 days following symptom assessment stratified by the ESAS score*.
See this image and copyright information in PMC

References

    1. Schriber JR, Hari PN, Ahn KW, Fei M, Costa LJ, Kharfan-Dabaja MA, et al. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: a CIBMTR report. Cancer. 2017;123:3141–9. doi: 10.1002/cncr.30747. - DOI - PMC - PubMed
    1. Mian HS, Fiala MA, Wildes TM. Burden of treatment among older adults with newly diagnosed multiple myeloma. Clin Lymphoma Myeloma Leuk. 2021;21:e152–e9. doi: 10.1016/j.clml.2020.09.010. - DOI - PMC - PubMed
    1. Panattoni L, Fedorenko C, Greenwood-Hickman MA, Kreizenbeck K, Walker JR, Martins R, et al. Characterizing potentially preventable cancer- and chronic disease-related emergency department use in the year after treatment initiation: a regional study. J Oncol Pract. 2018;14:e176–e85. doi: 10.1200/JOP.2017.028191. - DOI - PubMed
    1. Laugsand EA, Sprangers MA, Bjordal K, Skorpen F, Kaasa S, Klepstad P. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes. 2010;8:104. doi: 10.1186/1477-7525-8-104. - DOI - PMC - PubMed
    1. Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000;88:2164–71. doi: 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5. - DOI - PubMed

Publication types